Search

Your search keyword '"Pfaender, Stephanie"' showing total 391 results

Search Constraints

Start Over You searched for: Author "Pfaender, Stephanie" Remove constraint Author: "Pfaender, Stephanie"
391 results on '"Pfaender, Stephanie"'

Search Results

4. Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents

5. Copper and silver thin film systems display differences in antiviral and antibacterial properties -- implications for the prevention of SARS-CoV-2 infections

7. Impact of low eGFR on the immune response against COVID-19

8. Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis

9. SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress

10. Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

13. The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.

16. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients

17. Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses

18. Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents

19. LY6E impairs coronavirus fusion and confers immune control of viral disease

20. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols

21. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

22. The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression

23. Immune protection against reinfection with nonprimate hepacivirus

24. Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses

26. Increased SARS‐CoV‐2 reactive low avidity T cells producing inflammatory cytokines in pediatric post‐acute COVID‐19 sequelae (PASC).

27. Significant Fade of Neutralizing Antibodies and Stable Cellular Immunity in 4 Times COVID-19 Vaccinated Noninfected Compared to COVID-19 Convalescent and 3 Times Vaccinated Hemodialysis Patients

28. Relevance of microRNAs in SARS-CoV-2 infection of primary human hepatocytes

29. SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity

32. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19

33. Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome

34. Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV

35. Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination

36. Comparison of disease-modifying anti-rheumatic drugs in inducing immunogenicity to SARS-CoV2 vaccines in adult patients with autoimmune musculoskeletal inflammatory rheumatic diseases

37. SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications

39. Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination

40. Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination

41. SARS-CoV-2 entry route impacts a range of downstream viral and cellular processes

42. Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization

44. Impact of low eGFR on the immune response against COVID-19

46. Mouthrinses against SARS-CoV-2 – High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial

47. Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses

49. Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk

Catalog

Books, media, physical & digital resources